Dr. Desai joined the Preclinical
Pharmacology Program (directed by Dr....
McLean Hospital Title: Associate Psychobiologist, Preclinical
Pharmacology Program Harvard Medical School Title: Assistant Professor of Psychiatry
McLean Hospital Title: Research Psychologist, Preclinical
Pharmacology Program Harvard Medical School Title: Assistant Professor of Psychiatry
The Johns Hopkins Cancer Center establishes one of the nation's first cancer
pharmacology programs and begins developing and testing novel drugs and compounds for the treatment of cancer.
Not exact matches
Antonio Jose Lapa, professor of
pharmacology at the Universidade Federal de São Paulo, shares his vision on Brazil?s promising autochthonic medicine
programs.
Pharmacology - Toxicology
Program, National Institute of General Medical Sciences, Bethesda, Maryland 20014
and
Pharmacology - Toxicology
Program, National Institute of General Medical Scienes, Bethesda
program is to teach students the
pharmacology of the drugs and which drugs are used for what conditions, Pharm.D.
«Little is known about the mechanisms that might explain the role of saturated fat intake in obesity,» said Ordovás, who is also a member of the Genetics and
Pharmacology & Experimental Therapeutics graduate
program faculty at the Sackler School of Graduate Biomedical Sciences at Tufts University.
Le Novère trained in molecular and cellular
pharmacology and taught himself computer
programming and bioinformatics.
Jordi Mestres, coordinator of the IMIM and UPF research group on Systems
Pharmacology at the Biomedical Informatics
Program (GRIB) states «With this study we have contributed to complementing the detection of these quite unstable fragments, with information on the mechanism of action of the drug, based on three aspects: similarity to other medicines, prediction of their pharmacological profile, and interference with specific biological pathways.
Scientists at the National Institute on Drug Abuse (NIDA) Intramural Research
Program (IRP) have uncovered evidence that shows a more complex and elaborate role for the body's hard - working G protein - coupled receptors (GPCRs) than previously thought, suggesting a conceptual advance in the fields of biochemistry and
pharmacology.
These
programs support a variety of science majors, such as chemistry, biology,
pharmacology, and chemical toxicology.
The OACD, under the leadership of Joan Lakoski, assistant vice chancellor for the OACD and professor of
pharmacology at the University of Pittsburgh, has developed a new
program called the «Postdoctoral Professionalism» series.
Wayne Bowen, biology professor and co-director of the Molecular
Pharmacology, Physiology and Biotechnology Graduate
program at Brown University, agrees that reaching African - American students at a young age is crucial.
In fact, UCSB was first in the nation to offer an undergraduate degree in
pharmacology (the
program started in 1974) as a basic science — that is, not related to pharmacy training.
«We are at a point in our research where we have validated the efficacy of this combination treatment approach in preclinical animal models, and we now need to define its safety through toxicology and
pharmacology studies,» says Fisher, Thelma Newmeyer Corman Endowed Chair in Cancer Research and co-leader of the Cancer Molecular Genetics research
program at VCU Massey, chairman of VCU School of Medicine's Department of Human and Molecular Genetics and director of the VCU Institute of Molecular Medicine.
The new work was done under the auspices of the Innovative Genomics Initiative (IGI), a joint UC Berkeley - UCSF
program co-directed by Berkeley's Jennifer Doudna, PhD, and Jonathan Weissman, PhD, professor of cellular and molecular
pharmacology at UCSF and a Howard Hughes Medical Institute (HHMI) investigator.
Dr. Lunn is also
program coordinator for the Biochemical
Pharmacology Steering Committee at the New York Academy of Sciences, and a member of the Society for Laboratory Automation Screening Education Advisory Committee.
He then moved to the State University of New York in Buffalo where he held an Assistant Professorship in the Department of
Pharmacology and Therapeutics, and he served as the Director of Graduate Studies in the Molecular
Pharmacology and Cancer Therapeutics Graduate
Program.
«Our findings suggest new ways of tackling the still - difficult task of working out which patients should receive which drug and how drugs should be combined to maximize therapeutic benefit,» said senior study author Peter Sorger, the Otto Krayer Professor of Systems
Pharmacology and director of the Harvard
Program in Therapeutic Science and the Laboratory of Systems
Pharmacology at Harvard Medical School.
During his time at UCSF, he has served as the Director of the Cell Biology
Program (4 years) and Vice-Chair (10 years) and Chair of the Dept. of Cellular and Molecular
Pharmacology (5 years).
Matt Boersma»04 Honors student with Seth Ramus, now at Johns Hopkins University, graduate student in Neuroscience Scott Herrick»04 Honors student with Seth Ramus, now at Rockefeller University, technician in the lab of Bruce McEwen Emily Thompkins»03 Tufts University School of Veterinary Medicine Alexis Goldstein»03 Independent Study Research with Seth Ramus, now at The Pacific College of Oriental Medicine, graduate student Christopher Johnson»03 Laboratory technician at Brandeis University Kirsten George»03 Laboratory technician at Bowdoin (in professor thompson's lab) Kelly Dakin»02 Currently in the neuroscience grad
program at Harvard Tyler Dunphee»02 Currently in medical school at U. Minnesota Lauren Axelrod»02 Currently in medical school at University Wisconsin Yen Wing Chu»01 Currently in the neuroscience grad
program at Johns Hopkins Channing Paller»01 Currently an MD / PhD student at Harvard Shiva Gupta»01 Currently in Med School at New York Medical College Andrew Evans»01 Currently in the neuroscience grad
program at U. Bristol in England Shawn Pelletier»01 Currently in
pharmacology grad
program at University Connecticut
-- Receipt of a $ 1 million research grant award from the PA Department of Health's CURE
program to support development of nanotechnology to deliver cancer - fighting medications directly into cancer cells, work done by Mark Kester,
pharmacology.
Previously, Lang served as the
program director for the T32 postdoctoral training grant titled «Training Program in Trauma and Organ Injury,» and currently lectures graduate student courses in physiology and pharma
program director for the T32 postdoctoral training grant titled «Training
Program in Trauma and Organ Injury,» and currently lectures graduate student courses in physiology and pharma
Program in Trauma and Organ Injury,» and currently lectures graduate student courses in physiology and
pharmacology.
Our research
program aims at producing an inspiring scientific environment where clinical research and basic research in urology and urological
pharmacology interact on a daily basis.
Since 2000 Head of Lymphocyte Activation Unit Division of Immunology, Transplantation and Infectious Diseases
Program in Immunology, Bio-Immuno-gene therapy of Cancer, IRCCS Ospedale San Raffaele, Milan, Italy 1998 - 1999 Research Associate Department of Molecular Biology and Functional Genomic, IRCCS Ospedale San Raffaele, Milan, Italy 1993 - 1998 Postdoctoral Associate Department of Microbiology University of Minnesota, Medical School Minneapolis, MN, USA 1991 - 1992 Department of
Pharmacology, New York University, New York, USA 1989 - 1991 Department of Biomedical Science and Oncology, Turin, Italy 1988 - 1989 Research Fellow Department of Biomedical Science and Oncology, Turin, Italy 1989 - 1992 Ph.D. student in Molecular Oncology 1986 - 1988 Undergraduate student Department of Biomedical Science and Oncology, Turin, Italy
Shridar Ganesan, MD, PhD Omar Boraie Chair in Genomic Science Associate Director for Translational Science Director of Functional Genomics Shared Resource Co-Leader, Clinical Investigations and Precision Therapeutics
Program Chief, Molecular Oncology Rutgers Cancer Institute of New Jersey Associate Professor of Medicine and
Pharmacology Rutgers Robert Wood Johnson Medical School
Under the terms of the new agreement, AstraZeneca and Moderna, a pioneer of mRNA Therapeutics ™, have agreed to collaborate on two specific immuno - oncology
programs, based on promising pre-clinical data, including
pharmacology in tumor models.
Dr. Sadelain is also a member of the departments of medicine and pediatrics at Memorial Hospital and the molecular
pharmacology and chemistry
program of the Sloan Kettering Institute.
Health and Medicine Research ADHD autism brain Center for Integrative and Cognitive Neuroscience Craig Lindsley David Zald Doug Fuchs education Elaine Sanders - Bush event - related potential featured research fmri Ford Ebner Frank Tong Fridolin Sulser Institute of Imaging Science Isabel Gauthier Jeff Balser Jeffrey Conn Jeffrey Schall Jejoong Kim John Gore Jon Kaas language Lynn Fuchs mark wallace Multisensory Research Laboratory Neurogenomics neurology neuroscience Neuroscience Graduate
Program neurosurgery Nicholas Hobbs NIMH Parkinson's disease Paul Yoder PET
pharmacology psychiatry psychology psychopharmacology Randolph Blake Randy Blakely Rene Marois Robert Kessler Ronald Cowan schizophrenia Sean Polyn Silvio O. Conte Center for Neuroscience Research Sohee Park special education Stephen Heckers Susan Gray vanderbilt brain institute Vanderbilt One Hundred Oaks vanderbilt vision research center
Carmot is advancing multiple
programs toward clinical development and is seeking an ambitious and experienced scientist to lead non-clinical
pharmacology, toxicology, and IND - enabling studies.
Dr. Mucke — who is also a professor of neurology and the Joseph B. Martin Distinguished Professor of Neuroscience at the University of California, San Francisco, with which Gladstone is affiliated — wins the award along with Yueming Li, PhD, member and professor at the Sloan - Kettering Institute, and director of the Graduate
Program in
Pharmacology at Weill Medical College of Cornell University.
Even after he formally retired, Hoffmann continued to teach in the part - time Master of Liberal Arts
program, where his classes focused on the social and political implications of
pharmacology.
Hong - Gang Wang, PhD (D Club) Lois High Bestler Professor of Pediatrics and
Pharmacology; Director, Pediatrics Molecular Oncology
Program «Ca2 + induced apoptosis through calcineurin dephosphorylation of BAD» Science, April 1999 860 citations, Web of Science, April 1, 2017
The
program is headed by a joint steering committee comprising two Roche researchers and two UC San Diego faculty members, Joan Heller Brown, PhD, professor and chair of the Department of
Pharmacology, and Michael K. Gilson, MD, PhD, professor of pharmacy and pharmaceutical sciences and director of UCSD's new Drug Discovery Institute.
Molecular basis of scouting behaviors in honey bees Zhengzheng Liang, Neuroscience
Program, University of Illinois at Urbana - Champaign, USA Dissociating epigenetic mechanisms of memory in the hippocampus and perirhinal cortex of rats Krista Mitchnick, Department of Psychology, Collaborative Neuroscience
Program, University of Guelph, Guelph, ON, Canada Determining the heritability of locomotor sensitization to ethanol and its relationship to ethanol's positive motivational effects in mice David Linsenbardt, Indiana Alcohol Research Center and Department of Psychology, Indiana University — Purdue University, Indianapolis, Indianapolis, Indiana, USA Rufy1 or Hnrnph1 is a likely quantitative trait gene for methamphetamine sensitivity Camron Bryant, Laboratory of Addiction Genetics, Department of
Pharmacology and Experimental Therapeutics, Department of Psychiatry, Boston University School of Medicine, Massechusetts, USA
In 1996, Dr. Lukas established the Behavioral Psychopharmacology Research Laboratory (BPRL), which includes
programs in clinical trials / outpatient research, human
pharmacology and pharmacokinetics, human electrophysiology, natural settings, and clinical chemistry.
«As a person who was from the Midwest, I fell in love with the diversity and the vibrancy of Philadelphia... and I was really interested in a lot of the research going on there,» he said of his decision to join the university's
program in biochemistry and molecular
pharmacology.
Yang Xiang, PhD, assistant professor of neurobiology at University of Massachusetts Medical School, has received a three - year, $ 900,000 grant from the Human Frontiers Science
Program to lead an international team of scientists, including Gang Han, PhD, assistant professor of biochemistry & molecular
pharmacology, in the development and implementation of a new optogenetic platform that can remotely activate neurons inside a free - moving organism.
This is a structured
program in which trainees receive in - depth education through a core clinical research curriculum and participation in clinical research training in one of five specialized training tracks: clinical
pharmacology, neuro - oncology, cell and gene therapy, leukemia or solid tumor.
Training towards the PhD degree in immunology spans four graduate
programs - Physiology,
Pharmacology / Toxicology, the new
Program in Experimental and Molecular Medicine (PEMM), and Molecular and Cellular Biology (MCB), with the latter containing the majority of the participating faculty and students.
He has augmented his training with extensive postgraduate studies in nutritional and herbal
pharmacology along with certification as a master practitioner of Neuro - Linguistic
Programming.
During the first two years of the
program they are trained in the same basic science and clinical applications that traditional medical students are educated in, in addition to
pharmacology.
He additionally has a Master's Degree in
Pharmacology and Immunology, and was a doctoral candidate in the Medical Scientist
Program assisting with Clinical Trials of new medications as well as part of the Heart Disease Reversal Team with Dr. Dean Ornish.
Combining research with foundational theory, the
program offers an in - depth education covering the principles of health and wellness; herb identification and harvesting; herbal pharmacy; herbal
pharmacology and phytochemistry; integrative human physiology; Materia Medica; and herbal therapeutics.
Department of Pharmaceutical Sciences,
Pharmacology / Toxicology Graduate
Program, College of Pharmacy, Washington State University, Pullman, 99164 - 6534, USA.
Department of Pharmaceutical Sciences and
Pharmacology / Toxicology Graduate
Program, College of Pharmacy, Washington State University, Pullman 99164, USA.
The
program covers topics such as anatomy and physiology, radiology, parasitology, medical and surgical nursing, anesthesia,
pharmacology.
Most
programs offer similar curricula, focusing on anatomy, physiology, terminology, parasitology,
pharmacology, dentistry, diagnostics, microbiology, radiology, animal nursing, behavior, nutrition, and practice management.